Discoveries of hydrogen sulfide as a novel cardiovascular therapeutic

Circulation Journal

Volumn 78, Issue 9, 2014, Pages 2111-2118

  Barr, Larry A ^a   Calvert, John W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardioprotection; Cytoprotection; Gasotransmitters; Hydrogen sulfide

Indexed keywords

3 METACAPTOPYRUVATE SULFURTRANSFERASE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ATV 346; CARBON MONOXIDE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HEAT SHOCK PROTEIN 90; HEME OXYGENASE 1; HYDROGEN SULFIDE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE; NAPROXEN DERIVATIVE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SULFURTRANSFERASE; THIOREDOXIN 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; CARDIOTONIC AGENT; GASOTRANSMITTER;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELL PROTECTION; CHEMICAL PHENOMENA; CLINICAL TRIAL (TOPIC); HEART PROTECTION; HUMAN; LIVER PROTECTION; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; RENAL PROTECTION; REVIEW; SIGNAL TRANSDUCTION; SULFHYDRATION; UPREGULATION; VASODILATATION; APOPTOSIS; DRUG EFFECTS; METABOLISM;

ANTIOXIDANTS; APOPTOSIS; CARDIOTONIC AGENTS; GASOTRANSMITTERS; HUMANS; HYDROGEN SULFIDE; VASODILATION;

EID: 84906819088     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0728     Document Type: Review

References (76)

1. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 2006; 40: 119-130.
2. Wang R. Two’s company, three’s a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J 2002; 16: 1792-1798.
3. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, et al. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 2010; 122: 11-19.
4. Goodwin LR, Francom D, Dieken FP, Taylor JD, Warenycia MW, Reiffenstein RJ, et al. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: Postmortem studies and two case reports. J Anal Toxicol 1989; 13: 105-109.
5. Kondo K, Bhushan S, King AL, Prabhu SD, Hamid T, Koenig S, et al. H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 2013; 127: 1116-1127.
6. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, et al. H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
7. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004; 18: 1165-1167.
8. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 2003; 5: 493-501.
9. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-935.
10. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007; 6: 662-680.
11. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
12. Dou D, Zheng X, Liu J, Xu X, Ye L, Gao Y. Hydrogen peroxide enhances vasodilatation by increasing dimerization of cGMP-dependent protein kinase type Iα. Circ J 2012; 76: 1792-1798.
13. Elrod JW, Greer JJ, Bryan NS, Langston W, Szot JF, Gebregzlabher H, et al. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 2006; 26: 1517-1523.
14. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2004; 286: H276-H282.
15. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: A putative neural messenger. Science 1993; 259: 381-384.
16. Choi AM, Otterbein LE. Emerging role of carbon monoxide in physiologic and pathophysiologic states. Antioxid Redox Signal 2002; 4: 227-228.
17. Ryter SW, Choi AM. Heme oxygenase-1: Molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 2002; 4: 625-632.
18. Foresti R, Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999; 31: 459-475.
19. Marshall HE, Stamler JS. Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB. Am J Respir Cell Mol Biol 1999; 21: 296-297.
20. Calvert JW, Coetzee WA, Lefer DJ. Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid Redox Signal 2010; 12: 1203-1217.
21. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, et al. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 2009; 11: 703-714.
22. Nagahara N, Nagano M, Ito T, Shimamura K, Akimoto T, Suzuki H. Antioxidant enzyme, 3-mercaptopyruvate sulfurtransferase-knockout mice exhibit increased anxiety-like behaviors: A model for human mercaptolactate-cysteine disulfiduria. Sci Rep 2013; 3: 1986.
23. Kimura H. Physiological role of hydrogen sulfide and polysulfide in the central nervous system. Neurochem Int 2013; 63: 492-497.
24. Nicholson CK, Calvert JW. Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 2010; 62: 289-297.
25. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, et al. Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 1995; 92: 1585-1589.
26. Beard RS Jr, Bearden SE. Vascular complications of cystathionine beta-synthase deficiency: Future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 2011; 300: H13-H26.
27. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-531.
28. Beauchamp RO Jr, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 1984; 13: 25-97.
29. Polhemus DJ, Lefer DJ. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 2014; 114: 730-737.
30. Cheng Y, Ndisang JF, Tang G, Cao K, Wang R. Hydrogen sulfideinduced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 2004; 287: H2316-H2323.
31. Zhu XY, Liu SJ, Liu YJ, Wang S, Ni X. Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide- treated macrophages. Cell Mol Life Sci 2010; 67: 1119-1132.
32. Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009; 29: 173-179.
33. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006; 20: 2118-2120.
34. Yan SK, Chang T, Wang H, Wu L, Wang R, Meng QH. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 351: 485-491.
35. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756-763.
36. Maron BA, Michel T. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J 2012; 76: 2497-2512.
37. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation: The two keystones of ischemia/reperfusion injury. Int J Cardiol 2002; 86: 41-59.
38. Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: A review. Curr Med Chem 2007; 14: 1539-1549.
39. Fisher CD, Augustine LM, Maher JM, Nelson DM, Slitt AL, Klaassen CD, et al. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metab Dispos 2007; 35: 995-1000.
40. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 2009; 106: 21972-21977.
41. Polhemus D, Kondo K, Bhushan S, Bir SC, Kevil CG, Murohara T, et al. Hydrogen sulfide attenuates cardiac dysfunction following heart failure via induction of angiogenesis. Circ Heart Fail 2013; 6: 1077-1086.
42. Givvimani S, Munjal C, Gargoum R, Sen U, Tyagi N, Vacek JC, et al. Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol 2011; 110: 1093-1100.
43. Hill BC, Woon TC, Nicholls P, Peterson J, Greenwood C, Thomson AJ. Interactions of sulphide and other ligands with cytochrome c oxidase: An electron-paramagnetic-resonance study. Biochem J 1984; 224: 591-600.
44. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther 2006; 319: 1405-1412.
45. Stride N, Larsen S, Hey-Mogensen M, Hansen CN, Prats C, Steinbruchel D, et al. Impaired mitochondrial function in chronically ischemic human heart. Am J Physiol Heart Circ Physiol 2013; 304: H1407-H1414.
46. Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science 2005; 308: 518.
47. Kimura Y, Goto Y, Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 2010; 12: 1-13.
48. Yin J, Tu C, Zhao J, Ou D, Chen G, Liu Y, et al. Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats. Brain Res 2013; 1491: 188-196.
49. Lin X, Yu S, Chen Y, Wu J, Zhao J, Zhao Y. Neuroprotective effects of diallyl sulfide against transient focal cerebral ischemia via antiapoptosis in rats. Neurol Res 2012; 34: 32-37.
50. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: Role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 2008; 295: H801-H806.
51. Fu Z, Liu X, Geng B, Fang L, Tang C. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 2008; 82: 1196-1202.
52. Xu Z, Prathapasinghe G, Wu N, Hwang SY, Siow YL. Ischemia- reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. Am J Physiol Renal Physiol 2009; 297: F27-F35.
53. Johansen D, Ytrehus K, Baxter GF. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury: Evidence for a role of K ATP channels. Basic Res Cardiol 2006; 101: 53-60.
54. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560-15565.
55. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, et al. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 2008; 33: 906-913.
56. Liu L, Liu H, Sun D, Qiao W, Qi Y, Sun H, et al. Effects of H(2)S on myogenic responses in rat cerebral arterioles. Circ J 2012; 76: 1012-1019.
57. Baukrowitz T, Fakler B. KATP channels gated by intracellular nucleotides and phospholipids. Eur J Biochem 2000; 267: 5842-5848.
58. Usachev YM, Marsh AJ, Johanns TM, Lemke MM, Thayer SA. Activation of protein kinase C in sensory neurons accelerates Ca2+ uptake into the endoplasmic reticulum. J Neurosci 2006; 26: 311-318.
59. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009; 105: 365-374.
60. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 2004; 101: 2040-2045.
61. Churchill EN, Mochly-Rosen D. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans 2007; 35: 1040-1042.
62. Aon MA, Cortassa S, Akar FG, O’Rourke B. Mitochondrial criticality: A new concept at the turning point of life or death. Biochim Biophys Acta 2006; 1762: 232-240.
63. Thomas RL, Gustafsson AB. Mitochondrial autophagy: An essential quality control mechanism for myocardial homeostasis. Circ J 2013; 77: 2449-2454.
64. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008-6016.
65. Zhang QY, Du JB, Zhang CY, Tang CS. The regulation of carbon monoxide/heme oxygenase system by hydrogen sulfide in rats with hypoxic pulmonary hypertension. Zhonghua Jie He He Hu Xi Za Zhi 2004; 27: 659-663 (in Chinese).
66. Majid AS, Majid AM, Yin ZQ, Ji D. Slow regulated release of H2S inhibits oxidative stress induced cell death by influencing certain key signaling molecules. Neurochem Res 2013; 38: 1375-1393.
67. Olson KR. A practical look at the chemistry and biology of hydrogen sulfide. Antioxid Redox Signal 2012; 17: 32-44.
68. Nagy P, Palinkas Z, Nagy A, Budai B, Toth I, Vasas A. Chemical aspects of hydrogen sulfide measurements in physiological samples. Biochim Biophys Acta 2014; 1840: 876-891.
69. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, et al. H2S signals through protein S-sulfhydration. Sci Signal 2009; 2: ra72.
70. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001; 2001: pl1.
71. Kohr MJ, Aponte A, Sun J, Gucek M, Steenbergen C, Murphy E. Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: Short communication. Circ Res 2012; 111: 1308-1312.
72. Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto I. Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. Hepatogastroenterology 2004; 51: 1404-1407.
73. Predmore BL, Kondo K, Bhushan S, Zlatopolsky MA, King AL, Aragon JP, et al. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 2012; 302: H2410-H2418.
74. Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): New insights into the biology of hydrogen sulfide. Circulation 2008; 117: 2351-2360.
75. Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br J Pharmacol 2010; 159: 1236-1246.
76. Elsheikh W, Blackler RW, Flannigan KL, Wallace JL. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer. Nitric Oxide 2014 April 18, doi:10.1016/j.niox.2014.04.006.